Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

1,757 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Pathway-based association analysis of genome-wide screening data suggest that genes associated with the gamma-aminobutyric acid receptor signaling pathway are involved in neuroleptic-induced, treatment-resistant tardive dyskinesia.
Inada T, Koga M, Ishiguro H, Horiuchi Y, Syu A, Yoshio T, Takahashi N, Ozaki N, Arinami T. Inada T, et al. Among authors: koga m. Pharmacogenet Genomics. 2008 Apr;18(4):317-23. doi: 10.1097/FPC.0b013e3282f70492. Pharmacogenet Genomics. 2008. PMID: 18334916
DPP6 as a candidate gene for neuroleptic-induced tardive dyskinesia.
Tanaka S, Syu A, Ishiguro H, Inada T, Horiuchi Y, Ishikawa M, Koga M, Noguchi E, Ozaki N, Someya T, Kakita A, Takahashi H, Nawa H, Arinami T. Tanaka S, et al. Among authors: koga m. Pharmacogenomics J. 2013 Feb;13(1):27-34. doi: 10.1038/tpj.2011.36. Epub 2011 Aug 9. Pharmacogenomics J. 2013. PMID: 21826085
Genome-wide association study identifies a potent locus associated with human opioid sensitivity.
Nishizawa D, Fukuda K, Kasai S, Hasegawa J, Aoki Y, Nishi A, Saita N, Koukita Y, Nagashima M, Katoh R, Satoh Y, Tagami M, Higuchi S, Ujike H, Ozaki N, Inada T, Iwata N, Sora I, Iyo M, Kondo N, Won MJ, Naruse N, Uehara-Aoyama K, Itokawa M, Koga M, Arinami T, Kaneko Y, Hayashida M, Ikeda K. Nishizawa D, et al. Among authors: koga m. Mol Psychiatry. 2014 Jan;19(1):55-62. doi: 10.1038/mp.2012.164. Epub 2012 Nov 27. Mol Psychiatry. 2014. PMID: 23183491 Free PMC article. Clinical Trial.
Replication study and meta-analysis of the genetic association of GRM3 gene polymorphisms with schizophrenia in a large Japanese case-control population.
Albalushi T, Horiuchi Y, Ishiguro H, Koga M, Inada T, Iwata N, Ozaki N, Ujike H, Watanabe Y, Someya T, Arinami T. Albalushi T, et al. Among authors: koga m. Am J Med Genet B Neuropsychiatr Genet. 2008 Apr 5;147(3):392-6. doi: 10.1002/ajmg.b.30610. Am J Med Genet B Neuropsychiatr Genet. 2008. PMID: 17948896
Supportive evidence for reduced expression of GNB1L in schizophrenia.
Ishiguro H, Koga M, Horiuchi Y, Noguchi E, Morikawa M, Suzuki Y, Arai M, Niizato K, Iritani S, Itokawa M, Inada T, Iwata N, Ozaki N, Ujike H, Kunugi H, Sasaki T, Takahashi M, Watanabe Y, Someya T, Kakita A, Takahashi H, Nawa H, Arinami T. Ishiguro H, et al. Among authors: koga m. Schizophr Bull. 2010 Jul;36(4):756-65. doi: 10.1093/schbul/sbn160. Epub 2008 Nov 14. Schizophr Bull. 2010. PMID: 19011233 Free PMC article.
Brain cannabinoid CB2 receptor in schizophrenia.
Ishiguro H, Horiuchi Y, Ishikawa M, Koga M, Imai K, Suzuki Y, Morikawa M, Inada T, Watanabe Y, Takahashi M, Someya T, Ujike H, Iwata N, Ozaki N, Onaivi ES, Kunugi H, Sasaki T, Itokawa M, Arai M, Niizato K, Iritani S, Naka I, Ohashi J, Kakita A, Takahashi H, Nawa H, Arinami T. Ishiguro H, et al. Among authors: koga m. Biol Psychiatry. 2010 May 15;67(10):974-82. doi: 10.1016/j.biopsych.2009.09.024. Epub 2009 Nov 22. Biol Psychiatry. 2010. PMID: 19931854
1,757 results